A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Flumioxazin | CAS 103361-09-7 - Request Quote

Picture of Flumioxazin
SZ CAT No:SZ-F093001
CAS No
103361-09-7
Mol.F.
C19H15FN2O4
Mol.Wt.
354.3
Inv. Status
Synthesis on demand
Shipping Condition Room Temperature

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Flumioxazin is chemically 2-(7-Fluoro-3-oxo-4-(prop-2-yn-1-yl)-3,4-dihydro-2H-benzo[b][1,4]oxazin-6-yl)-4,5,6,7-tetrahydro-1H-isoindole-1,3(2H)-dione. Flumioxazin is supplied with detailed characterization data compliant with regulatory guideline. Flumioxazin can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Flumioxazin.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

Buy 103361-09-7

Purchase 103361-09-7

Order 103361-09-7

Enquire 103361-09-7

price of 103361-09-7

103361-09-7 Supplier

103361-09-7 Manufacturer

103361-09-7 Exporter

buy high quality Flumioxazin

Purchase Flumioxazin

Flumioxazin suppliers

Flumioxazin manufacturers

Flumioxazin price

Order Flumioxazin

Enquire Flumioxazin

Flumioxazin cost

Flumioxazin Supplier

Flumioxazin Distributor

Flumioxazin for Method Validation

Flumioxazin Reference Standard

Flumioxazin for ANDA Filing

Flumioxazin for Forced Degradation Studies

Flumioxazin Identification Standards

Flumioxazin for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,